MX9301410A - Composiciones farmaceuticas en aerosol conteniendo la sustancia activa flezelastina y estructuras afines. - Google Patents

Composiciones farmaceuticas en aerosol conteniendo la sustancia activa flezelastina y estructuras afines.

Info

Publication number
MX9301410A
MX9301410A MX9301410A MX9301410A MX9301410A MX 9301410 A MX9301410 A MX 9301410A MX 9301410 A MX9301410 A MX 9301410A MX 9301410 A MX9301410 A MX 9301410A MX 9301410 A MX9301410 A MX 9301410A
Authority
MX
Mexico
Prior art keywords
active substance
flezelastina
pharmaceutical compositions
related structures
aerosol containing
Prior art date
Application number
MX9301410A
Other languages
English (en)
Inventor
Helmut Hettche
Juergen Engel
Original Assignee
Asta Medica Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Asta Medica Ag filed Critical Asta Medica Ag
Publication of MX9301410A publication Critical patent/MX9301410A/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/007—Pulmonary tract; Aromatherapy
    • A61K9/0073—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy
    • A61K9/008—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy comprising drug dissolved or suspended in liquid propellant for inhalation via a pressurized metered dose inhaler [MDI]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/12—Aerosols; Foams
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pulmonology (AREA)
  • Dispersion Chemistry (AREA)
  • Otolaryngology (AREA)
  • Immunology (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

Se describen aérosoles de dosificación con la sustancia activa flezelastina, el agente propulsor 2H heptafluorpropano (TG 227) y/o 1,1,1,2 tetrafluoretano (TG 134a) y el estabilizador de la suspensión TagatR TO, TagatR O y TagatR O2 como así el procedimiento para la elaboración de la formulación.
MX9301410A 1992-03-17 1993-03-15 Composiciones farmaceuticas en aerosol conteniendo la sustancia activa flezelastina y estructuras afines. MX9301410A (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE4208545 1992-03-17

Publications (1)

Publication Number Publication Date
MX9301410A true MX9301410A (es) 1993-09-01

Family

ID=6454293

Family Applications (1)

Application Number Title Priority Date Filing Date
MX9301410A MX9301410A (es) 1992-03-17 1993-03-15 Composiciones farmaceuticas en aerosol conteniendo la sustancia activa flezelastina y estructuras afines.

Country Status (12)

Country Link
EP (1) EP0561166A1 (es)
JP (1) JPH0616539A (es)
KR (1) KR930019204A (es)
CN (1) CN1080852A (es)
AU (1) AU3526193A (es)
BR (1) BR9301172A (es)
CA (1) CA2091713A1 (es)
FI (1) FI931159A7 (es)
HU (1) HU9300747D0 (es)
MX (1) MX9301410A (es)
NO (1) NO930946L (es)
ZA (1) ZA931875B (es)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5635159A (en) * 1994-08-26 1997-06-03 Abbott Laboratories Aerosol drug formulations containing polyglycolyzed glycerides
GB9426252D0 (en) * 1994-12-24 1995-02-22 Glaxo Group Ltd Pharmaceutical composition
GB9807232D0 (en) 1998-04-03 1998-06-03 Univ Cardiff Aerosol composition
HU229798B1 (en) * 2001-03-30 2014-07-28 Jagotec Ag Medical aerosol compositions and process for their preparation
ES2259915B1 (es) * 2005-03-15 2007-12-16 Laboratorio Aldo-Union, S.A. Nueva formulacion estable de aerosoles en suspension y procedimiento de obtencion.

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0222191B1 (de) * 1985-11-11 1991-01-30 ASTA Pharma AG 4-Benzyl-1-(2H)-phthalazinon-Derivate

Also Published As

Publication number Publication date
FI931159L (fi) 1993-09-18
JPH0616539A (ja) 1994-01-25
KR930019204A (ko) 1993-10-18
AU3526193A (en) 1993-09-23
FI931159A7 (fi) 1993-09-18
HU9300747D0 (en) 1993-05-28
NO930946L (no) 1993-09-20
EP0561166A1 (de) 1993-09-22
NO930946D0 (no) 1993-03-16
BR9301172A (pt) 1993-09-21
ZA931875B (en) 1993-10-06
CA2091713A1 (en) 1993-09-18
FI931159A0 (fi) 1993-03-16
CN1080852A (zh) 1994-01-19

Similar Documents

Publication Publication Date Title
DK0553298T3 (da) Aerosolformulering omfattende beclomethason-17,21-dipropionat
ES2176355T3 (es) Formulaciones de aerosol de peptidos y proteinas.
NO990454L (no) Aerosol-materiale
DE59804534D1 (de) Medizinische aerosolformulierungen
NO173998C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive benzimidazolderivater
ES2071306T3 (es) El uso de tensioactivos fluorados solubles para la preparacion de formulaciones aerosoles dosificadas.
NO170125C (no) Fremgangsmaate for fremstilling av lagringsstabile, hurtigopploeselige, farmasoeytiske virkestoff-presslegemer
ES2126766T3 (es) 7-azaindol-3-ilcarboxiamidas de tropilo como agente antitusivo.
DK1303258T3 (da) Hidtil ukendte aerosolformuleringer, der indeholder et polært, floureret molekyle
ATE202931T1 (de) Taxanderivate enthaltende arzneizubereitungen
DE3583916D1 (de) Waessrige arzneiformulierungen des piroxicammonohydrats.
SV1998000119A (es) Formulacion medicamentosa con liberacion controlada de sustancia activa. ref. lea 32671-sv
NO980858D0 (no) Farmasöytiske preparater og anordninger for administrering derav
ES2159148T3 (es) Formulaciones en aerosol de furoato de mometasona libres de clorofluorocarbonos.
AR012480A1 (es) Una unidad de dosis farmaceutica que comprende tibolona, un metodo para elaborarla y el uso de un producto de almidon como vehiculo en unidades dedosis farmaceuticas que comprenden tibolona
CU22412A1 (es) Una mezcla natural compuesta por alcoholes alifaticos primarios superiores obtenidos de la cera de abejas para el tratamiento de las ulceras gastricas y duodenales que presenta tambien actividad antiinflamatoria
MX9301410A (es) Composiciones farmaceuticas en aerosol conteniendo la sustancia activa flezelastina y estructuras afines.
ES2077559T3 (es) Estabilizacion de proteinas terapeuticamente activas en preparados farmaceuticos.
GB2021409A (en) Pharmaceutical composition
DE3866198D1 (de) Pharmazeutische zubereitung fuer die intrarektale verabreichung von calcitonin und daraus hergestellte einzeldosisformen.
SE8704049D0 (sv) Novel pharmacological compounds
TH29519B (th) สูตรผสมทางเภสัชศาสตร์ที่เสถียรชนิดใหม่สำหรับการผลิตละอองลอยที่ไม่มีแก๊สผลักดัน